1.
Wang L, Knight K, Lucas C, Clark R. The role of serial BCR-ABL transcript monitoring in predicting the emergence of BCR-ABL kinase mutations in imatinib-treated patients with chronic myeloid leukemia. Haematologica [Internet]. 2006Feb.1 [cited 2026Nov.16];91(2):235-9. Available from: https://haematologica.org/article/view/3849